Objective: It is known that prostaglandin E2 (PGE2) plays a crucial role in the ovulation process. PGE2 mediates its actions through four subtypes of receptors designated EP1 -EP4. However, the nature of the ovulation-promoting effect of PGE2 is not well understood. We have carried out this in vivo research utilizing a new selective EP4 receptor agonist (EP4A; APS-999 Na) to investigate its role in folliculogenesis aiming at more understanding of the biological mechanism of action of PGE2. Design and methods: Immature, 22 day old Wistar rats were used. Animals were injected once either with placebo, 20 IU pregnant mare serum gonadotrophin (PMSG), or EP4A (10, 20 or 50 mg). In other experiments, EP4A was injected in PMSG stimulated rats. Ovarian follicle growth and development was assessed through total count and size measurement of ovulatory follicles in whole ovaries of the investigated groups. Utilizing immunohistochemistry, the spatial localization of the EP4 receptor in immature rat ovary and IL-8 pattern of expression after EP4A injection was also investigated. Results: Our study showed that injection of EP4A resulted in increased follicle growth and development compared with the control, in a time-and dose-dependent manner. The highest values for follicle count and size were observed 12 and 24 h after EP4A injection. EP4A induced follicle growth with morphological characteristics similar to that induced by the standard PMSG. Most dense immune staining for EP4 receptor was noticed in proliferating granulosa cells of the secondary follicles while those of the primordial and primary follicles were not stained. EP4A injection induced the expression of IL-8 in the follicles. Conclusions: Our study revealed that: (i) the localization of EP4 receptor in the ovary implies a role in follicle growth, (ii) PGE2 induced ovarian follicle growth and development is mediated at least in part through the EP4 receptor, (iii) the action of EP4A is mediated through IL-8 up regulation and (iv) the new EP4A could be a promising reagent for various systems used to induce follicle maturation in clinical or agricultural fields. This knowledge may provide useful targets for manipulation of infertility.
Introduction
The characteristics of reproduction in mammals differ widely. Inspite of these differences common mechanisms regulate ovarian function. In the ovary, developmental processes comprising cell proliferation, differentiation and apoptosis occur in an extreme way, not only throughout the fetal and prepubertal stages but also during the adult life. Folliculogenesis is a multi-regulated process. At each stage of follicular development, both extracellular factors of endocrine or paracrine origin and intracellular factors direct follicular cells towards proliferation, differentiation or apoptosis.
Ovulation in mammals shares many characteristics of an inflammatory-like reaction and large-scale evidence suggests a crucial role of prostaglandins (PG), particularly PGE2, in this process (1 -4) . PGE2 is synthesized from arachidonic acid by cyclooxygenase enzyme (COX) and mediates many of its effects by binding to four subtypes of receptors designated; EP1, EP2, EP3, and EP4 (5, 6) . EP2 and EP4 receptors activate adenylate cyclase and lead to increased levels in intracellular cAMP. EP1 activation is associated with increase in intracellular Ca 2þ and EP3 inhibits intracellular cAMP levels. Even though the active role of PG in the ovulatory process is well established, the precise mechanism of action, or which receptor is involved, is not well understood.
The active role of PGE2 in ovulation has been verified by numerous investigations. High doses of indomethacin (an inhibitor of COX-1 and COX-2) can block ovulation in rats (2, 7, 8) . Absence of COX-2 in mice leads to defects in ovulation, fertilization and implantation (9) . Targeted disruption of the COX-2 gene in mice results in female infertility due to impairment of the ovulatory process (10, 11) , while disruption of the COX-1 gene did not result in an ovarian phenotype.
Follicular PG synthesis is dramatically increased in the hours preceding ovulation in several species, and the administration of inhibitors of the biosynthesis of PG were shown to block follicular rupture (2 -4) . Significant increase in the concentrations of PGE2 was detected in follicular fluid aspirated from preovulatory follicles after human chorionic gonadotrophin (hCG) administration (12) . PGE2 was shown to induce cumulus expansion in vitro (13) . Additionally, cumulus cell oocyte complexes (COCs) obtained from rats and mice after superovulation were shown to synthesize PGE1, PGE2, and PGF2a (14) . Treatment of these COCs with indomethacin greatly reduces the in vitro fertilization rate of oocytes, and this effect is reversed if PGE1 and PGE2 are added to the media in the presence of the indomethacin.
Recently, a highly selective novel EP4 receptor agonist (EP4A; APS-999 Na) has been developed. Taking into account the important roles of PGE2 in the ovulation process mentioned above, the present in vivo research was carried out to explore whether the new EP4A has a positive impact on ovarian follicle growth in the rat, aiming at better understanding of the underlying mechanism of action of PGE2. Immunohistochemistry, morphologic, and morphometric analysis were used.
Materials and methods

Experimental design
Morphologic and morphometric studies These were designed to investigate the role of a novel EP4A (APS-999 Na, Toray Industries, Inc., Tokyo, Japan) in the process of ovarian follicular growth and development in the immature rat. In group A exogenous EP4A injections were administered following pregnant mare serum gonadotrophin (PMSG) priming, and in group B the effects of EP4A directly injected without priming was studied (Fig. 1 ).
Immunohistochemical studies These were designed to investigate: (i) the spatial localization of the EP4 antigen in ovaries of immature rats that received no injections (group C) and (ii) the effect of exogenous EP4A injection on the expression of IL-8. For this purpose we selected www.eje-online.org rats from group B that received either an injection of saline or 50 mg EP4A and were killed 24 h after the last injection. Experiments were performed in triplicates.
Animals
Twenty two day old female Wistar-Albino rats at around 50 g body weight were used in the study. Animals were purchased from Japan SLC Co. Hamamatsu, Japan. Rats were maintained under specific pathogenfree conditions in the laboratory animal center of Hamamatsu University School of Medicine, Japan with free access to food and water. They were kept in 12 h light:12 h darkness with temperature 23^1 8C and humidity 55^5% (^S.E.M.). Animals were killed with a lethal dose of ether according to an animal protocol that was approved by the animal care and use committee of Hamamatsu University School of Medicine.
Drug treatments ( 
Antibodies
Affinity isolated polyclonal anti-interleukin-8 antibody was used at a dilution of 0.5 mg/ml (Sigma Chemical Co., St Louis, MO, USA, product number 18 026). According to manufacturer specifications, the antibody shows no cross-reactivity with other cytokines. EP4 receptor polyclonal antiserum (Cayman Chemical Co., Ann Arbor, MI, USA; product number 101770) was used at a dilution of 1:1000. According to manufacturer specifications, the antibody shows cross-reactivity to human monocytes, neutrophils, and Mono Mac cells (monocytic cell line) but not to other PGE2 receptor subtypes.
Immunohistochemistry
Immunohistochemistry was performed using the streptavidin -biotin -peroxidase complex method (SAB) (15) . Ovarian sections were deparaffinized in xylene baths, rehydrated through descending grades of alcohol, and rinsed in PBS (pH 7.2). Slides were incubated with 0.3% hydrogen peroxide in methanol for 20 min to block endogenous peroxidase activity. After washing, they were treated with normal goat serum for 30 min to block non-specific binding.
Primary antibodies were then applied at the appropriate dilutions and incubated in 2% BSA (Sigma) in PBS overnight at 4 8C. After washing, slides were incubated with biotinylated secondary antibody for 45 min, followed by incubation with avidin -biotin -peroxidase complex (Vectastatin kit, Burlingame, CA, USA) for 30 min. Reaction products were visualized after incubation with 0.025% diaminobenzidine and 0.003% hydrogen peroxide. Nuclear staining was done with hematoxylin. Slides were dehydrated and mounted. Positive staining was recognized as a brown color. All incubations were performed in a moist chamber. Negative control stainings were conducted by replacing all the primary antibodies by their non-immune IgG isotypes at the same concentrations.
Light microscopy
The extracted ovaries were immediately fixed in 20% formaline in water, processed and embedded in paraffin. The embedded ovaries were serially sectioned (5 mm). For morphological and morphometric analyses, every 10 th of 100 sections/ovary was used. Paraffin sections were dewaxed in xylene, rehydrated in descending concentrations of ethanol, washed in distilled water, and stained with hematoxylin (for 5 min, followed by a wash in water and acetic alcohol before staining with eosin for 20 s. Slides were then dehydrated in ascending concentrations of ethanol and xylene to be mounted.
Morphological characterization of ovarian follicles
Stages of follicular development observed using a Leitz microscope were classified following Wulff et al. (16) as primordial follicles (the oocyte is surrounded by a single layer of squamous cells), primary follicles (the oocyte is surrounded by a single layer of cuboidal granulosa cells, GCs), early secondary follicles (the oocyte is surrounded by two to four layers of cuboidal GCs without an antrum), late secondary follicles (the oocyte is surrounded by more than four layers of GCs without an antrum and the theca is evident), tertiary follicles (follicles containing an antrum), and ovulatory follicles (follicles with large continuous antral space). Healthy follicles were recognized by having a normal shaped oocyte surrounded by GCs that were regularly apposed on an intact basement membrane with a normal appearance of granulosa cell nuclei without signs of pyknosis.
Morphometric assessment of follicular development
This was achieved through two means: (i) enumeration of the total number of tertiary (antral) and ovulatory follicles present in whole ovaries from animals belonging to the groups investigated and (ii) measurement of the follicular areas (mm) for the largest five follicles/ovarian section. Both follicle count and diameter measurement were performed at different time points to characterize the dynamics of follicle development over time. 
Image analysis
Statistical analysis
Data are presented as mean^S.E.M. All statistical analyses were performed on absolute values. Differences between groups were tested by one-way ANOVA and unpaired two-tailed Student's t-test. Significance was assumed at P , 0.05. The tests were performed using SPSS version 6.1 for Macintosh (SPSS, Inc., Chicago, IL, USA).
Results
Localization of the EP4 receptor in the rat ovary
This was investigated in ovarian sections of immature rats that did not receive any injections (group C). Ovaries showed follicles at various stages of development. Immunostaining revealed that the distribution and labeling intensity were different from primordial to mature follicles during folliculogenesis (Fig. 2) .
EP4 immunoreactivity in GCs was weak or absent in primordial to multilayered stages of primary follicles, but increased gradually when follicles differentiated to secondary follicles. In primordial follicles, the oocytes were positively stained unlike their surrounding squamous pregranulosa cells. Immune reactivity was most prominent in proliferating GCs of the secondary follicles. Mature follicles with a large continuous antral cavity revealed positive staining in their oocytes but weak staining of the GCs.
Positive immune staining for EP4 was also noticed in the cytoplasm of the endothelial cells and pericapillary area and in blood vessels surrounding the follicles in the stroma of the ovary. Weak immune staining was sometimes seen in the theca interna cells. 
Localization of IL-8 in the rat ovary
Immunohistochemistry staining for IL-8 was performed in immature rats either injected with saline (control group B) or 50 mg EP4A (EP4A group B) to explore the impact of EP4A injection on the expression of IL-8. Immune staining revealed different distribution and labeling intensity between both groups (Fig. 3) . In the control group, weak positive staining was only observed in the ovarian stroma (Fig. 3a) , while, in the EP4A group dense positive immune staining for IL-8 was induced in the follicles in addition to the stroma (Fig. 3b) . Follicular positive staining was localized at the oocytes, granulosa, and theca cell layers. The staining pattern was comparable to that of the EP4 antigen previously described.
Effect of EP4A injection on follicle growth and development
The effect of exogenous EP4A injection on the process of follicle growth in the immature rat was investigated in comparison with that induced by PMSG using follicle count and follicle diameter measurements. Examination was done utilizing light microscopy and HE stained slides.
Group A (EP4A injection after PMSG priming) Control ovarian sections revealed dominance of primordial and primary follicles while antral and ovulatory follicles were small populations. The medulla of the ovaries was largely occupied by loose connective tissue containing ovarian vasculature. Ovarian sections of EP4A and PMSG groups delineated conspicuous increases in the antral and ovulatory follicles occupying the ovarian cortex and medulla. The medullary blood vessels were dilated and congested. EP4A injection induced a highly significant increase in follicle count at 12 (22.5^1.7, P , 0.001) and 24 h (22.2^2.2, P , 0.001) compared with the control (10^0.3) . PMSG injections demonstrated nearly similar results at the same time points (17.8^2.1 and 19.7^1.4), respectively. At 48 h, follicle count was decreased for EP4A (14.4^2.3, P , 0.05) and PMSG (15.4^2.9) (Fig. 4) .
Follicle diameter measurements resembled those of the ovarian follicle count at the three time points compared with the control (2.1^0.12) (Fig. 5) . At 12, 24, and 48 h, follicle diameters for EP4A were 3.3^0.10 (P , 0.001), 3.0^0.12 (P , 0.01), and 3.3^0.15 (P , 0.05) respectively. At the same time points, PMSG were 3.2^0.06, 2.8^0.12, and 3.1^0.10. Group B injections (without PMSG priming) EP4A injection without PMSG resulted in follicle growth, shown by increases in follicle counts and diameters at all time points studied compared with the control.
Follicle count was highest at 12 h, being 17^0.2 (P , 0.01) for EP4A and 19^1.3 for PMSG, compared with the control (4^0.2). At 24, 36, and 48 h the EP4A group showed follicle counts of 11.5^1.3, 11^2.1, and 11.5^0.9 (P , 0.05) respectively. At the same time points, the PMSG group counts were 12^1.01, 12^0.6, and 13^1.6 (Fig. 6) .
Follicle diameter measurements for the EP4A group were 1.52^0.2 (P , 0.01), 1.62^0.18 (P , 0.01), 1.32^0.1 (P , 0.05), and 1.53^0.13 (P , 0.05) at 12, 24, 36, and 48 h respectively. For PMSG, they were 1.34^0.26, 1.34^0.09, 1.48^0.19, and 1.4^0.15 at 12, 24, 36, and 48 h respectively (Fig. 7 ).
EP4A injections with rising doses EP4A injections in rising doses (10, 20, or 50 mg) revealed an increase in follicle diameter in a dose dependent manner compared with the control. They were 2.8^0.17 (P , 0.05), 2.7^0.15 (P , 0.05), 3.3^0.18 (P , 0.001), and 2.0^0.17 respectively (Fig. 8) .
There was no statistically significant difference in follicle counts and diameter measurements between EP4A and PMSG injections in either group A or B.
Discussion
Folliculogenesis is divided into two phases, basal and terminal follicular growth. In preantral follicles, paracrine rather than endocrine factors are important. However, terminal follicular growth is strictly a gonadotrophin-dependent process (17, 18) . Numerous studies have reported the temporal and spatial expression pattern of COX in the ovary in cyclic rats or in response to trophic hormone treatment (19 -23) . These investigations demonstrated that trophic hormone administration induced the expression of COX, thus implying an essential role for PGE2 in the terminal differentiation of ovarian follicles.
So far the specific receptor(s) that mediates PGE2 actions has not been determined and is becoming a focus of intense research. In recent work, transcripts for PGE2 receptor subtypes EP2 and EP4 were expressed in freshly isolated human ovarian granulosa cells (24) . In another study, the expression of mRNA for PGE2 receptor subtypes EP2 and EP4 was shown in mouse periovulatory follicles during superovulation (25) . In addition, the authors demonstrated that hCG administration induced the expression of the signals for EP4 mRNA in granulosa and cumulus cells throughout superovulation until just before ovulation (25) . These reports suggest an important role for PGE2 EP2 and EP4 receptor subtypes in follicle development relying upon their expression pattern. In the present work using immunohistochemistry, the localization for EP4 receptor antigen was detected primarily in granulosa cells of secondary but not primordial or primary follicles implying a role in follicle growth. Furthermore, the induction of follicle development via exogenous administration of the EP4A adds additional evidence to a possible role for the EP4 receptor in the process of follicle growth and development. We demonstrated that EP4A induced follicle development when injected without the preceding PMSG stimulation, as evidenced from follicle count and diameter measurements. EP4A induced follicle growth in a time-and dose-dependent manner and with morphological characteristics similar to that induced by PMSG.
Ovulation is controlled by coordinated hormone responses involving the hypothalamus, pituitary, and ovary. Among the many mediators of this process, PGs play a key role in coordinating tissue responses at all levels, including preovulatory hormonal surges and ovulation (26, 27) . In the hypothalamus, PGs have been shown to stimulate the secretion of luteinizing hormone releasing hormone (LHRH) (28) , which leads to the release of the gonadotropins (29). Ojeda et al. (30) have reported that indomethacin inhibits the secretion of gonadotrophin-releasing hormone from the hypothalamus. Lau & Saksena (31) have observed that a single s.c. injection of 1 mg PGE2 stimulates the release of LH in ovariectomized rats. Also, ovulation can be restored in the COX-2 deficient animals by simultaneous treatment with gonadotropins and PGE2 (32) . Of note in the previous studies, the signaling systems that regulate the role of exogenous PGs in ovulation were time-and dose-dependent. In the present study, injection of EP4A induced follicle growth, as did PMSG administration. However, we did not observe significant difference in follicle count or diameter when EP4A was injected after PMSG treatment compared with PMSG alone. These results may be explained in view of the interaction between exogenous and the COX mediated PGE2 pathways in the ovulation process.
IL-8, a cytokine of the chemokine family, is produced by a number of cell types including peripheral blood monocytes, endothelial cells, fibroblasts, and neutrophils (33, 34) . Its known actions include chemotaxis and activation of neutrophils, expression of surface adhesion molecules on neutrophils, angiogenesis and mitogenesis of epidermal, melanoma, and vascular smooth muscle cells (35, 36) . In reproductive biology, it has been implicated in ovulation, menstruation, parturition and implantation (37 -39) . Recent studies demonstrated ovarian follicle growth and development mediated by IL-8 (40, 41) . To elucidate a correlation between EP4A and IL-8, we investigated the effect of exogenous injection of EP4A on the ovarian expression of IL-8 using immunohistochemical technique. We demonstrated that administration of the EP4A resulted in strong staining for IL-8 in the growing rat follicles. Most dense staining for IL-8 was noticed in GCs of growing secondary follicles. These results imply that EP4A-induced follicle growth and development may be mediated through IL-8 up-regulation. The exact mechanism of IL-8 up-regulation was not explored in this study. In accordance with our results, PGE2 was shown to mediate its actions in some tissues of the body through up-regulation of IL-8 production (42, 43) . In conclusion, the present study documented ovarian follicle development induced by exogenous injection of PGE2 EP4A in the immature rat for the first time. These results suggest that EP4A might be a promising compound to produce follicle growth and maturation in different programs as efficiently as the standard PMSG treatments.
